ArticlePhysics and imaging in radiation oncology2025
Deep learning combining imaging, dose and clinical data for predicting bowel toxicity after pelvic radiotherapy.
Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Optimizing the delivery of radiotherapy with artificial intelligence.Nature reviews. Clinical oncology · 2026Review
- An Agentic Multimodal Sensing Architecture for CT-Guided Wearable and Respiratory Monitoring in Oncology Care.Sensors (Basel, Switzerland) · 2026Article
- An integrated toolkit for structure generation, optimization, and evaluation in spatially fractionated radiation therapy.Journal of applied clinical medical physics · 2026Article
- AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy.Frontiers in oncology · 2026Review
- Functional Recovery After Chemotherapy- and Radiotherapy-Induced Gastrointestinal Injury: Mechanisms, Clinical Assessment, and Management.International journal of general medicine · 2026Review
- AI-enabled precision prediction and proactive management of cutaneous toxicities in cancer immunoradiotherapy (ICI+RT).Frontiers in oncology · 2026Review
- Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients.Physics and imaging in radiation oncology · 2026Article
- Mechanistic pathways predictive modeling and translational interventions for radiation enteritis in cervical cancer radiotherapy.Frontiers in cellular and infection microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: A comprehensive understanding of radiotherapy toxicity requires analysis of multimodal data. However, it is challenging to develop a model that can analyse both 3D imaging and clinical data simultaneously. In this study, a deep learning model is proposed for simultaneously analysing computed tomography scans, dose distributions, and clinical metadata to predict toxicity, and identify the impact of clinical risk factors and anatomical regions. Materials and methods: : A deep model based on multiple instance learning with feature-level fusion and attention was developed. The study used a dataset of 313 patients treated with 3D conformal radiation therapy and volumetric modulated arc therapy, with heterogeneous cohorts varying in dose, volume, fractionation, concomitant therapies, and follow-up periods. The dataset included 3D computed tomography scans, planned dose distributions to the bowel cavity, and patient clinical data. The model was trained on patient-reported data on late bowel toxicity. Results: Results showed that the network can identify potential risk factors and critical anatomical regions. Analysis of clinical data jointly with imaging and dose for bowel urgency and faecal incontinence improved performance (area under receiver operating characteristic curve [AUC] of 88% and 78%, respectively) while best performance for diarrhoea was when analysing clinical features alone (68% AUC). Conclusions: Results demonstrated that feature-level fusion along with attention enables the network to analyse multimodal data. This method also provides explanations for each input's contribution to the final result and detects spatial associations of toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.